DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/03/3111-1346-1351$20.00
DMD 31:1346-1351, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Q.-Y.
Right arrow Articles by Kaminsky, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Q.-Y.
Right arrow Articles by Kaminsky, L. S.

CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION

Qing-Yu Zhang, Debbie Dunbar, and Laurence S. Kaminsky

New York State Department of Health, Wadsworth Center, Albany, New York

The expression of biotransformation enzymes in mouse small intestine is poorly characterized, which limits the utility of transgenic or knockout mouse models for first-pass drug metabolism studies. In response, we have systematically examined the composition and inducibility of cytochrome P450 (P450) protein and mRNA in mouse small intestinal epithelial cells (enterocytes). RNA-PCR was conducted to confirm the expression and identity of CYP1A1, 1B1, 2B10, 2B19, 2B20, 2C29, 2C38, 2C40, 2E1, 3A11, 3A13, 3A16, 3A25, and 3A44 in the enterocytes of untreated mice, but CYP1A2, 2A4/5, 2A12, 2C37, 2C39, and 2F2 were not detected. The inducibility of CYP2B, 2C, and 3A subfamily forms was determined by real-time quantitative RNA-PCR. All five CYP3A forms were induced, in a range from 1.7- to 4.5-fold, by dexamethasone (DEX). Phenobarbital (PB) induced CYP2B9, CYP2B10, and CYP2B20 mRNAs and suppressed CYP2B19 mRNA levels. PB also induced CYP2C29 and CYP2C40, but not CYP2C38 mRNA. At the protein level, CYP1A1, CYP1B1, CYP2B, CYP2C, CYP2E1, and CYP3A were detected in enterocytes from untreated mice by immunoblot analysis. CYP1A1 was inducible by ß-naphthoflavone (BNF), CYP2B and CYP2C by PB, and CYP3A by DEX. CYP2B, 2C, and 3A proteins were all expressed at high levels proximally, and decreased distally. The inducibility of CYP1A1 followed a similar pattern. Intestinal P450 expression was compared between C57BL/6 (B6) and 129/sv (129) mice, strains commonly used in the preparation of transgenic and knockout mouse models. There was no significant strain difference in constitutive levels or induction patterns for CYP2B, 2C, and 3A protein. However, CYP1A1 was induced to a high level by BNF in B6 mice, but was not induced in the 129 mice.


Address correspondence to: Dr. Laurence S. Kaminsky, New York State Department of Health, Wadsworth Center, P.O. Box 509, Albany, NY 12201-0509. E-mail: kaminsky{at}wadsworth.org




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Q.-Y. Zhang, C. Fang, J. Zhang, D. Dunbar, L. Kaminsky, and X. Ding
An Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral Nifedipine
Drug Metab. Dispos., March 1, 2009; 37(3): 651 - 657.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate
Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates
Cancer Res., September 15, 2008; 68(18): 7394 - 7402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Bulckaen, G. Prevost, E. Boulanger, G. Robitaille, V. Roquet, C. Gaxatte, G. Garcon, B. Corman, P. Gosset, P. Shirali, et al.
Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1562 - H1570.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q.-Y. Zhang, L. S. Kaminsky, D. Dunbar, J. Zhang, and X. Ding
Role of Small Intestinal Cytochromes P450 in the Bioavailability of Oral Nifedipine
Drug Metab. Dispos., September 1, 2007; 35(9): 1617 - 1623.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. G. Hernandez and P.-G. Forkert
Inhibition of vinyl carbamate-induced mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F1 (Big Blue(R) x A/J) transgenic mice
Carcinogenesis, August 1, 2007; 28(8): 1824 - 1830.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. D. Finn, A. W. McLaren, D. Carrie, C. J. Henderson, and C. R. Wolf
Conditional Deletion of Cytochrome P450 Oxidoreductase in the Liver and Gastrointestinal Tract: A New Model for Studying the Functions of the P450 System
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 40 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Pan, F. N. Hussain, J. Iqbal, M. H. Feuerman, and M. M. Hussain
Inhibiting Proteasomal Degradation of Microsomal Triglyceride Transfer Protein Prevents CCl4-induced Steatosis
J. Biol. Chem., June 8, 2007; 282(23): 17078 - 17089.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Uno, T. P. Dalton, N. Dragin, C. P. Curran, S. Derkenne, M. L. Miller, H. G. Shertzer, F. J. Gonzalez, and D. W. Nebert
Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate
Mol. Pharmacol., April 1, 2006; 69(4): 1103 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. A. Symonds, K. P. Miller, D. Tomic, and J. A. Flaws
Effect of Methoxychlor and Estradiol on Cytochrome P450 Enzymes in the Mouse Ovarian Surface Epithelium
Toxicol. Sci., February 1, 2006; 89(2): 510 - 514.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K.-i. Fujita, Y. Ando, M. Narabayashi, T. Miya, F. Nagashima, W. Yamamoto, K. Kodama, K. Araki, H. Endo, and Y. Sasaki
GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
Drug Metab. Dispos., December 1, 2005; 33(12): 1785 - 1790.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. Wolf, S. G. Wood, J. A. Hunt, B. W. Walton-Strong, K. Yasuda, L. Lan, S. X. Duan, Q. Hao, S. A. Wrighton, E. H. Jeffery, et al.
ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
Drug Metab. Dispos., December 1, 2005; 33(12): 1827 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
K. A. Kruger, J. W. Blum, and D. L. Greger
Expression of Nuclear Receptor and Target Genes in Liver and Intestine of Neonatal Calves Fed Colostrum and Vitamin A
J Dairy Sci, November 1, 2005; 88(11): 3971 - 3981.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert
Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation
Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Zhuo, J. Gu, M. J. Behr, P. J. Swiatek, H. Cui, Q.-Y. Zhang, Y. Xie, D. N. Collins, and X. Ding
Targeted Disruption of the Olfactory Mucosa-Specific Cyp2g1 Gene: Impact on Acetaminophen Toxicity in the Lateral Nasal Gland, and Tissue-Selective Effects on Cyp2a5 Expression
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 719 - 728.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. S. Kaminsky and Q.-Y. Zhang
THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN
Drug Metab. Dispos., December 1, 2003; 31(12): 1520 - 1525.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.